Literature DB >> 6192749

Antibiotics and steroids in the treatment of acquired subglottic stenosis. A canine model study.

J S Supance.   

Abstract

The efficacy of a combination of systemic antibiotics and a steroid in the prevention of acquired subglottic stenosis (ASGS) was evaluated employing a previously developed canine animal model. Thirty-five healthy, postweanling mongrel puppies aged 5 weeks were each intubated for 14 days with an uncuffed polyvinyl endotracheal tube. Twenty puppies received intramuscular dexamethasone (1 mg) daily, and procaine penicillin (100,000 IU) and dihydrostreptomycin (0.125 g) in two divided doses on the day of intubation and each day thereafter until the completion of the study. The remaining 15 puppies served as a control group and received no medical therapy. Animals from both groups were killed at 5, 7, 12, 15, 20, 30, and 56 days following intubation. Comparative examinations of the laryngotracheal complexes of treated and control dogs showed that there was no significant difference between the two groups in the ultimate degree of ASGS attained, as determined by intraluminal cross-sectional area analysis, or in the extent of the lesion as documented by gross and microscopic histology. This investigation showed that the specific systemic combination of two antibiotics and a steroid used in the study was not efficacious in the prevention of ASGS in a canine animal model; for this reason we question the benefit of analogous medical regimens employed to prevent ASGS in infants and children who require long-term endotracheal intubation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192749     DOI: 10.1177/000348948309200417

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  [Subglottic tracheal stenosis].

Authors:  N Karaiskaki; W J Mann
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 2.  [Pediatric respiratory tract stenoses: are subspecialization and the development of specialist centers necessary?].

Authors:  G Friedrich
Journal:  HNO       Date:  2006-12       Impact factor: 1.284

3.  Rapamycin inhibits human laryngotracheal stenosis-derived fibroblast proliferation, metabolism, and function in vitro.

Authors:  Daryan R Namba; Garret Ma; Idris Samad; Dacheng Ding; Vinciya Pandian; Jonathan D Powell; Maureen R Horton; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2015-03-09       Impact factor: 3.497

4.  T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.

Authors:  Alexander T Hillel; Dacheng Ding; Idris Samad; Michael K Murphy; Kevin Motz
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

5.  A comparison of the efficacy of 5-fluorouracil/triamcinolone, carnitine and dexamethasone therapy on wound healing in tracheal injury: potential for preventing tracheal stenosis?

Authors:  Mehmet Guven; Fatih Turan; Ahmet Eyibilen; Ali Akbaş; Ünal Erkorkmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-17       Impact factor: 2.503

6.  Role of Topical Medication in Prevention of Post-extubation Subglottic Stenosis.

Authors:  Saravanam Prasanna Kumar; Arunachalam Ravikumar; Johnson Thanka
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-17

7.  Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis.

Authors:  Alexander T Hillel; Sharon S Tang; Camila Carlos; Joseph H Skarlupka; Madhu Gowda; Linda X Yin; Kevin Motz; Cameron R Currie; Garret Suen; Susan L Thibeault
Journal:  mSphere       Date:  2019-05-01       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.